Protecting Veterinary Needs for Compounding

Compounding affects veterinarians and their patients every day. That’s why the AVMA is very carefully considering whether or how our compounding policies should be revised. We hear from veterinarians that they have needs outside of what the policies currently say, which is why the volunteer veterinarians on AVMA’s governance groups (many of whom are practitioners) are having discussions right now about what approach our policies on Compounding and Compounding from Unapproved (Bulk) Substances should take.

We’re working on our policies now because compounding legislation is being drafted on Capitol Hill.  If the AVMA does not communicate the needs of its members during these legislative discussions, then we lose an opportunity to shape that legislation. If we don’t get this right, other interests could prevail, and veterinarians and their patients could lose. We understand the policies have to be carefully considered, so stay tuned because we are going to ask AVMA members for their feedback on any proposed revisions. The volunteer veterinarians who make the decisions for the AVMA are going to carefully consider that feedback.

Realize there are possible benefits and costs associated with policy revisions, which the AVMA would use as a basis for legislative discussions. We hear from veterinarians often about the need for access to Food and Drug Administration (FDA)-approved drugs, so keep in mind that the marketplace (i.e., the proportion of available FDA-approved drugs to commercially available compounds from bulk) could change in some way if compounding legislation ultimately passes.

Later this month, we will be sharing with members proposed revisions to our compounding policies and giving the members at least 30 days to review them. Please look for more on AVMA@Work and in our NOAH member-only discussion forums. We know this issue is complicated (for example, some products available in the marketplace are actually illegal mimics of FDA-approved drugs), so to help you sort through all of the issues and conversation, we’ll be developing some educational materials about what the rules actually say. We will also be keeping AVMA members apprised of what our Governmental Relations Division is doing on Capitol Hill about compounding to assist our members.




5 thoughts on “Protecting Veterinary Needs for Compounding

  1. Currently I work in a feline only practice. So many of these kitties need drugs that have no veterinarian equivalent and need to be compounded for the correct dosage. In addition, many of my patients do NOT willingly take medication. For those kitties, we can generally find a compounded formulation that the owner can administer to the cat. I use compounded drugs from a compounding pharmacy alot for my patients’ well being. The proposed rules would severely limit my ability to correctly medicate my patients and limit the owners’/clients’ options for ways to adequately to treat their kitties.

  2. This could be devastating to all DVM’s, especially those who do a lot of exotic and feline work. There will be literally no place they could go to get the medications they need, and their patients will surely suffer from any legislation barring them from getting medications compounded.

  3. EXOTIC ANIMALS: As an exotic animal practitioner, limiting compounding would certainly increase the suffering, morbidity, and mortality of my patients. Many medications used in these species aren’t available locally and the delay of 24 hours or longer to get the right medication compounded specifically for that patient and delivered from a distance would be fatal for many patients.

  4. As a small animal general practitioner for 45 years, I frequently use a compounding pharmacy for drugs that a not available, not the correct strength or in a form that the owners can’t give. I oppose the proposed rules that would severely limit my and my client’s options for suitable medication dosages and forms.